"False"
Umeå University
printicon
Main menu hidden.
Staff photo Jonatan Salzer

Jonatan Salzer

Consultant neurologist, Associate professor.

Research qualifications: Docent
0000-0002-9205-0771

Contact

E-mail
jonatan.salzer@umu.se
Phone

Works at

Affiliation
Associate professor, senior consultant (attending) physician at Department of Clinical Sciences Section: Neurosciences
Location
Visiting address, view map

I work as a consultant neurologist at Neuro-Huvud-Hals-Centrum with acute stroke treatment. My research focus on rehab and diagnostics in acute vertigo, in-hospital stroke, treatment of multiple sclerosis and prevention of post-lumbar puncture headache.

Rituximab treatment in pediatric-onset multiple sclerosis
European Journal of Neurology, John Wiley & Sons 2024, Vol. 31, (5)
Breu, Markus; Sandesjö, Fredrik; Milos, Ruxandra-Iulia; et al.
Human herpesvirus 6A and axonal injury before the clinical onset of multiple sclerosis
Brain, Oxford University Press 2024, Vol. 147, (1) : 177-185
Grut, Viktor; Biström, Martin; Salzer, Jonatan; et al.
Interactions between high seroreactivity to human herpes virus 6A and Epstein–Barr virus in MS development: a presymptomatic case–control study
Annals of Neurology, John Wiley & Sons 2024, Vol. 96, (2) : 302-305
Grut, Viktor; Biström, Martin; Salzer, Jonatan; et al.
Hypogammaglobulinaemia during rituximab treatment in multiple sclerosis: a Swedish cohort study
European Journal of Neurology, John Wiley & Sons 2024, Vol. 31, (8)
Hallberg, Susanna; Evertsson, Björn; Lillvall, Ellen; et al.
Trajectories of cognitive processing speed and physical disability over 11 years following initiation of a first multiple sclerosis disease-modulating therapy
Journal of Neurology, Neurosurgery and Psychiatry, BMJ Publishing Group Ltd 2024, Vol. 95, (2) : 134-141
Longinetti, Elisa; Englund, Simon; Burman, Joachim; et al.
Combat-MS: a population-based observational cohort study addressing the benefit–risk balance of multiple sclerosis therapies compared with rituximab
Annals of Neurology, John Wiley & Sons 2024, Vol. 96, (4) : 678-693
Piehl, Fredrik; Alping, Peter; Virtanen, Suvi; et al.
Dizziness and vertigo sick leave before and after insurance restrictions: a descriptive Swedish nationwide register linkage study
BMC Public Health, BioMed Central (BMC) 2024, Vol. 24, (1)
Zborayova, Katarina; Andersson Barrenäs, Marie-Louise; Granåsen, Gabriel; et al.
Characteristics of in-hospital stroke patients in Sweden: a nationwide register-based study
European Stroke Journal, Sage Publications 2023, Vol. 8, (3) : 777-783
Ben-Shabat, Ilan; Darehed, David; Eriksson, Marie; et al.
Predictors of patient-reported fatigue symptom severity in a nationwide multiple sclerosis cohort
Multiple Sclerosis and Related Disorders, Elsevier 2023, Vol. 70
Englund, Simon; Kierkegaard, Marie; Burman, Joachim; et al.
Free vitamin D3 index and vitamin D-binding protein in multiple sclerosis: A presymptomatic case-control study
European Journal of Neurology, John Wiley & Sons 2022, Vol. 29, (8) : 2335-2342
Grut, Viktor; Biström, Martin; Salzer, Jonatan; et al.
Systemic inflammation and risk of multiple sclerosis: a presymptomatic case-control study
Multiple Sclerosis Journal, Experimental, Translational and Clinical, Sage Publications 2022, Vol. 8, (4) : 1-4
Grut, Viktor; Biström, Martin; Salzer, Jonatan; et al.
COVID-19 clinical outcomes and DMT of MS patients and population-based controls
Annals of Clinical and Translational Neurology, John Wiley & Sons 2022, Vol. 9, (9) : 1449-1458
Longinetti, Elisa; Bower, Hannah; McKay, Kyla A.; et al.
Comparison Between the Video Head Impulse Test and Caloric Irrigation During Acute Vertigo
Indian Journal of Otolaryngology and Head and Neck Surgery, Springer 2022, Vol. 74, (Suppl. 3) : S4475-S4482
Olivecrona, Elin; Zborayova, Katarina; Barrenäs, Marie-Louise; et al.
Internet-based vestibular rehabilitation versus standard care after acute onset vertigo: a study protocol for a randomized controlled trial
Trials, Springer Nature 2022, Vol. 23, (1)
Surano, Solmaz; Grip, Helena; Öhberg, Fredrik; et al.
Safety and efficacy of rituximab versus dimethyl fumarate in patients with relapsing-remitting multiple sclerosis or clinically isolated syndrome in Sweden: a rater-blinded, phase 3, randomised controlled trial
Lancet Neurology, Elsevier 2022, Vol. 21, (8) : 693-703
Svenningsson, Anders; Frisell, Thomas; Burman, Joachim; et al.
Discontinuation and dose reduction of rituximab in relapsing-remitting multiple sclerosis
Journal of Neurology, Springer 2021, Vol. 268, (6) : 2161-2168
Boremalm, Malin; Sundström, Peter; Salzer, Jonatan
Rituximab in patients with pediatric multiple sclerosis and other demyelinating disorders of the CNS: Practical considerations
Multiple Sclerosis Journal, Sage Publications 2021, Vol. 27, (12) : 1814-1822
Ghezzi, Angelo; Banwell, Brenda; Bar-Or, Amit; et al.
Cytomegalovirus seropositivity is associated with reduced risk of multiple sclerosis: a presymptomatic case–control study
European Journal of Neurology, John Wiley & Sons 2021, Vol. 28, (9) : 3072-3079
Grut, Viktor; Biström, Martin; Salzer, Jonatan; et al.
Normative video head impulse test data in subjects with and without vascular risk factors
European Archives of Oto-Rhino-Laryngology, Springer Berlin/Heidelberg 2021, Vol. 278, (7) : 2619-2624
Hansson, Anders; Salzer, Jonatan
Variability of Normal Pressure Hydrocephalus Imaging Biomarkers with Respect to Section Plane Angulation: How Wrong a Radiologist Can Be?
American Journal of Neuroradiology, American Society of Neuroradiology 2021, Vol. 42, (7) : 1201-1207
Ryska, P.; Slezak, O.; Eklund, A.; et al.
Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients
Annals of Neurology, John Wiley & Sons 2020, Vol. 87, (5) : 688-699
Alping, Peter; Askling, Johan; Burman, Joachim; et al.
Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies
JAMA Neurology, American Medial Association 2020, Vol. 177, (2) : 184-191
Luna, Gustavo; Alping, Peter; Burman, Joachim; et al.
Radiological markers of idiopathic normal pressure hydrocephalus: Relative comparison of their diagnostic performance
Journal of the Neurological Sciences, Elsevier 2020, Vol. 408
Ryska, Pavel; Slezak, Ondrej; Eklund, Anders; et al.
Prevention of post-dural puncture headache: a randomized controlled trial
European Journal of Neurology, John Wiley & Sons 2020, Vol. 27 : 14-15
Salzer, Jonatan; Granåsen, Gabriel; Sundström, Peter; et al.
Prevention of post-dural puncture headache: a randomized controlled trial
European Journal of Neurology, Wiley-Blackwell 2020, Vol. 27, (5) : 871-877
Salzer, Jonatan; Granåsen, Gabriel; Sundström, Peter; et al.
Validation of the Swedish Multiple Sclerosis Register Further Improving a Resource for Pharmacoepidemiologic Evaluations
Epidemiology, Lippincott Williams & Wilkins 2019, Vol. 30, (2) : 230-233
Alping, Peter; Piehl, Fredrik; Langer-Gould, Annette; et al.
Natalizumab, rituximab and fingolimod as escalation therapy in multiple sclerosis
European Journal of Neurology, Vol. 26, (8) : 1060-1067
Boremalm, Malin; Juto, A.; Axelsson, M.; et al.
Quality of care in acute dizziness presentations
European Journal of Neurology, John Wiley & Sons 2019, Vol. 26, (S1) : 926-926
Granberg Sandlund, M.; Diamant, Anna; Granåsen, Gabriel; et al.
Effectiveness of care in acute dizziness presentations
European Archives of Oto-Rhino-Laryngology, Springer 2019, Vol. 276, (9) : 2389-2396
Granberg Sandlund, Mikael; Diamant, Anna; Granåsen, Gabriel; et al.
Risk of hypogammaglobulinemia in long-term treatment with rituximab in multiple sclerosis
Multiple Sclerosis Journal, Sage Publications 2019, Vol. 25 : 20-20
Hallberg, S.; Boremalm, Malin; Evertsson, B.; et al.
Inflammatory activity and vitamin D levels in an MS population treated with rituximab
Multiple Sclerosis Journal, Experimental, Translational and Clinical, Vol. 5, (1)
Linden, Johan; Granåsen, Gabriel; Salzer, Jonatan; et al.
Bilateralt bortfall av horisontell vestibulo-okulär reflex: ett tidigt och specifikt kliniskt tecken vid Wernickes encefalopati: [Bilateral loss of the horizontal vestibulo-ocular reflex in Wernicke encephalopathy: a specific and early clinical sign]
Läkartidningen, Svenska läkarförbundet 2019, Vol. 116, (5) : 204-207
Salzer, Jonatan; Zizka, Jan; Karlberg, Mikael
Comparative Effectiveness of Rituximab and Other Initial Treatment Choices for Multiple Sclerosis
JAMA Neurology, American Medical Association 2018, Vol. 75, (3) : 320-327
Granqvist, Mathias; Boremalm, Malin; Poorghobad, Amyar; et al.
Interaction should guide management decisions
American Journal of Neuroradiology, American Society of Neuroradiology 2018, Vol. 39, (5) : E57-E57
Johansson, Elias; Salzer, Jonatan
Dizziness and the Acute Vestibular Syndrome at the Emergency Department: A Population-Based Descriptive Study
European Neurology, S. Karger 2018, Vol. 79, (1–2) : 5-12
Ljunggren, Micaela; Persson, Julia; Salzer, Jonatan
Rituximab in multiple sclerosis: data from the swedish MS registry
Multiple Sclerosis Journal, SAGE PUBLICATIONS LTD 2016, Vol. 22 : 49-49
Alping, P.; Svenningsson, A.; Salzer, Jonatan; et al.
Rituximab versus Fingolimod after Natalizumab in Multiple Sclerosis Patients
Annals of Neurology, Vol. 79, (6) : 950-958
Alping, Peter; Frisell, Thomas; Novakova, Lenka; et al.
CSF neurofilament light: A universal risk biomarker in multiple sclerosis?
Neurology, Vol. 87, (11) : 1068-1069
Khalil, Michael; Salzer, Jonatan
Rituximab in paediatric onset multiple sclerosis: a case series
Journal of Neurology, Springer Berlin/Heidelberg 2016, Vol. 263, (2) : 322-326
Salzer, Jonatan; Lycke, Jan; Wickström, Ronny; et al.
How to minimize the risk for headache?: a lumbar puncture practice questionnaire study
IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE, Vol. 69, (11-12) : 397-402
Salzer, Jonatan; Rajda, Cecilia; Sundström, Peter; et al.
Rituximab in multiple sclerosis: a retrospective observational study on safety and efficacy
Neurology, Vol. 87, (20) : 2074-2081
Salzer, Jonatan; Svenningsson, Rasmus; Alping, Peter; et al.
Vitamin D and axonal injury in multiple sclerosis
Multiple Sclerosis Journal, Vol. 22, (8) : 1027-1031
Sandberg, L.; Bistrom, M.; Salzer, Jonatan; et al.
Superior efficacy and tolerability of rituximab as compared to fingolimod for MS patients switching from natalizumab due to positive JC virus serology
Multiple Sclerosis Journal, Sage Publications 2015, Vol. 21, (11) : 555-555
Alping, P.; Islam-Jakobsson, Protik; Novakova, L.; et al.
Rituximab in multiple sclerosis, a long term safety and efficacy study
Multiple Sclerosis Journal, Vol. 21 : 574-574
Islam-Jakobsson, P.; Alping, P.; Salzer, Jonatan; et al.
The only certain measure of the effectiveness of multiple sclerosis therapy is cerebrospinal neurofilament level - YES
Multiple Sclerosis Journal, Sage Publications 2015, Vol. 21, (10) : 1239-1240
Salzer, Jonatan
Are we minimizing the patients' risk for headache?: a lumbar puncture practice questionnaire study among European neurologists
Multiple Sclerosis Journal, Vol. 21 : 733-734
Salzer, Jonatan; Rajda, C.; Sundström, Peter; et al.
Rituximab in paediatric MS
Multiple Sclerosis Journal, Vol. 21 : 380-380
Salzer, Jonatan; Wickstrom, R.; Piehl, F.; et al.
Vitamin D and multiple sclerosis from epidemiology to prevention
Acta Neurologica Scandinavica, Vol. 132, (Supplement 199) : 56-61
Sundstrom, Peter; Salzer, Jonatan
Increasing prevalence of multiple sclerosis in Vasterbotten County of Sweden
Acta Neurologica Scandinavica, Vol. 132, (6) : 389-394
Svenningsson, Anders; Salzer, Jonatan; Vågberg, Mattias; et al.
The trials and tribulations of vitamin D: time for the ‘sunshine’ vitamin to come in out of the cold – or just more broken promises?
Expert review of Endocrinology & Metabolism, Informa Healthcare 2014, Vol. 9, (4) : 327-344
Leckstroem, Daniel; Salzer, Jonatan; Goldsmith, David
View publications in DiVA